MCKENZIE PITTMAN: Open Payments
NPI 1982148524 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$815 in 36 payments from 6 companies in 2025. Trend: 2023 $660 · 2024 $802 · 2025 $815
Food & beverage: $720Education: $95
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 14 | $328 |
| UCB, Inc. | 13 | $217 |
| Janssen Biotech, Inc. | 3 | $156 |
| Galderma Laboratories, L.P. | 3 | $50 |
| PFIZER INC. | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
Products named: DUPIXENT, Bimzelx, TREMFYA, CIBINQO, NEMLUVIO.
Industry payments across OK — which companies pay providers there.
